Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到27条与MRI有关的结果

Expert Consensus on the Colorectal Cancer Annotation of CT and MRI (2020)

2021年发布于 Chinese Journal of Radiology (China) 55卷第2期 所属人体系统：消化 | 结直肠肿瘤

无

Colorectal Cancer CT MRI Annotation Consensus
指南简介 原文链接
ACR Appropriateness Criteria® Primary Bone Tumors

2020年发布于 J Am Coll Radiol 17卷第5S期 所属人体系统：运动 | 骨肿瘤

American College of Radiology Appropriateness Criteria

AUC Appropriate Use Criteria Appropriateness Criteria Bone Scan Bone Tumor CT MRI PET/CT Radiography.
指南简介 原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging

2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

Collège National Des Gynécologues Et Obstétriciens Français

Borderline Frontière IRM MRI Ovaire Ovary Papillary Projection Ultrasonography Végétation Échographie.
指南简介 原文链接
ESUR/ESUI Consensus Statements on Multi-parametric MRI for the Detection of Clinically Significant Prostate Cancer: Quality Requirements for Image Acquisition, Interpretation and Radiologists' Training

2020年发布于 European Radiology 30卷第10期 所属人体系统：生殖 | 前列腺肿瘤

European Society of Urogenital Radiology EAU Section of Urologic Imaging

Multi-parametric MRI in the Diagnostic Pathway of Prostate Cancer Has a Well-established Upfront Role in the Recently Updated European Association of Urology Guideline and American Urological Association Recommendations. • Suboptimal Image Acquisition and Reporting at an Individual Level Will Result in Clinicians Losing Confidence in the Technique and Returning to the (non-MRI) Systematic Biopsy Pathway. Therefore It Is Crucial to Establish Quality Criteria for the Acquisition and Reporting of MpMRI. • to Ensure High-quality Prostate MRI Experts Consider Checking and Reporting of Image Quality Mandatory. Prostate Radiologists Must Attend Theoretical and Hands-on Courses Followed by Supervised Education and Must Perform Regular Self- and External Performance Assessments.
指南简介 原文链接
Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol for Clinical Trials in Brain Metastases

2020年发布于 Neuro-Oncology 22卷第6期 所属人体系统：其他 | 头颈部肿瘤

无

MRI Brain Metastases Imaging Protocol.
指南简介 原文链接
Structured Reporting of Solid and Cystic Pancreatic Lesions in CT and MRI: Consensus-Based Structured Report Templates of the German Society of Radiology (DRG)

2020年发布于 Rofo 192卷第7期 所属人体系统：消化 | 胰腺肿瘤

German Society of Radiology German Society for General and Visceral Surgery Working Group Oncological Imaging of the German Cancer Society and Other Radiologists Oncologists and Surgeons

Solid and Cystic Pancreatic Lesions CT MRI Reporting Consensus
指南简介 原文链接
Magnetic Resonance Imaging for Preoperative Staging of Pancreatic Cancer Based on the 8th Edition of AJCC Guidelines

2020年发布于 Journal of Gastrointestinal Oncology 11卷第2期 所属人体系统：消化 | 胰腺肿瘤

American Joint Committee on Cancer

Pancreatic Cancer Magnetic Resonance Imaging (MRI) Resectability Staging.
指南简介 原文链接
Consensus on Contouring Primary Breast Tumors on MRI in the Setting of Neoadjuvant Partial Breast Irradiation in Trials

2020年发布于 Pract Radiat Oncol 10卷第6期 所属人体系统：生殖 | 乳腺肿瘤

无

Breast Tumors MRI Neoadjuvant Breast Irradiation
指南简介 原文链接
Endometrial Cancer MRI Staging: Updated Guidelines of the European Society of Urogenital Radiology

2019年发布于 European Radiology 29卷第2期 所属人体系统：生殖 | 子宫肿瘤

European Society of Urogenital Radiology

Endometrial Cancer MRI Staging Guideline
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 输卵管癌

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancers (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete 6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended Or a Discussion with the Patient About Intraperitoneal Chemotherapy According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 输卵管癌

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancer (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介 原文链接
Whole-Body [18F]-FDG-PET/MRI for Oncology: a Consensus Recommendation

2019年发布于 Rofo 191卷第4期 所属人体系统：其他 | 诊断/检测/评估方法

Vorstand Der Deutschen Röntgengesellschaft (DRG) Und Der Deutschen Gesellschaft Für Nuklearmedizin (DGN)

Oncology 18F]-FDG-PET MRI Diagnosis Consensus
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 卵巢肿瘤

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancers (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete 6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended Or a Discussion with the Patient About Intraperitoneal Chemotherapy According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介 原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 卵巢肿瘤

FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN) Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF) La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)

An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers the Following Procedures Should Be Performed: an Omentectomy (at a Minimum Infracolic) an Appendectomy Multiple Peritoneal Biopsies Peritoneal Cytology (grade C) and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types Except the Expansile Mucinous Subtypes for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian Tubal and Primary Peritoneal Cancers a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B) as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e. Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian Tubal Or Primary Peritoneal Cancer (grade B). for Advanced Cancers Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介 原文链接
Rectal Cancer Lexicon: Consensus Statement from the Society of Abdominal Radiology Rectal & Anal Cancer Disease-focused Panel

2019年发布于 Abdom Radiol (NY) 44卷第11期 所属人体系统：消化 | 直肠癌

Society of Abdominal Radiology Disease Focused Panel in Rectal Cancer

Lexicon MRI Rectal Cancer Society of Abdominal Radiology Rectal & Anal Cancer Disease-Focused Panel Staging
指南简介 原文链接
ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women

2019年发布于 J Am Coll Radiol 11卷第11S期 所属人体系统：生殖 | 乳腺肿瘤

American College of Radiology

AUC Appropriate Use Criteria Appropriateness Criteria Breast MRI Breast Cancer Mammography Stage I Ultrasound
指南简介 原文链接
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer

2019年发布于 J Am Coll Radiol 16卷第11S期 所属人体系统：泌尿 | 肾癌

American College of Radiology

AUC Appropriate Use Criteria Appropriateness Criteria CT Diagnostic Imaging MRI Renal Cell Carcinoma Surveillance Ultrasound X-ray
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：其他 | 腹膜肿瘤

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接

人体系统

共搜索到27条 与MRI有关的结果

2021年 发布于 Chinese Journal of Radiology (China) 55卷 第2期 所属人体系统： 消化 | 结直肠肿瘤

无

2020年 发布于 J Am Coll Radiol 17卷 第5S期 所属人体系统： 运动 | 骨肿瘤

American College of Radiology Appropriateness Criteria

2020年 发布于 Gynecol Obstet Fertil Senol 48卷 第3期 所属人体系统： 生殖 | 卵巢肿瘤

Collège National Des Gynécologues Et Obstétriciens Français

2020年 发布于 European Radiology 30卷 第10期 所属人体系统： 生殖 | 前列腺肿瘤

European Society of Urogenital Radiology EAU Section of Urologic Imaging

2020年 发布于 Neuro-Oncology 22卷 第6期 所属人体系统： 其他 | 头颈部肿瘤

无

2020年 发布于 Rofo 192卷 第7期 所属人体系统： 消化 | 胰腺肿瘤

German Society of Radiology German Society for General and Visceral Surgery Working Group Oncological Imaging of the German Cancer Society and Other Radiologists Oncologists and Surgeons

2020年 发布于 Journal of Gastrointestinal Oncology 11卷 第2期 所属人体系统： 消化 | 胰腺肿瘤

American Joint Committee on Cancer

2020年 发布于 Pract Radiat Oncol 10卷 第6期 所属人体系统： 生殖 | 乳腺肿瘤

无

2019年 发布于 European Radiology 29卷 第2期 所属人体系统： 生殖 | 子宫肿瘤

European Society of Urogenital Radiology

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Eur J Obstet Gynecol Reprod Biol 236卷 第_期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷 第6期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Rofo 191卷 第4期 所属人体系统： 其他 | 诊断/检测/评估方法

Vorstand Der Deutschen Röntgengesellschaft (DRG) Und Der Deutschen Gesellschaft Für Nuklearmedizin (DGN)

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

2019年 发布于 Eur J Obstet Gynecol Reprod Biol 236卷 第_期 所属人体系统： 生殖 | 卵巢肿瘤

2019年 发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷 第6期 所属人体系统： 生殖 | 卵巢肿瘤

2019年 发布于 Abdom Radiol (NY) 44卷 第11期 所属人体系统： 消化 | 直肠癌

Society of Abdominal Radiology Disease Focused Panel in Rectal Cancer

2019年 发布于 J Am Coll Radiol 11卷 第11S期 所属人体系统： 生殖 | 乳腺肿瘤

American College of Radiology

2019年 发布于 J Am Coll Radiol 16卷 第11S期 所属人体系统： 泌尿 | 肾癌

American College of Radiology

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

共搜索到27条与MRI有关的结果

2021年发布于 Chinese Journal of Radiology (China) 55卷第2期 所属人体系统：消化 | 结直肠肿瘤

2020年发布于 J Am Coll Radiol 17卷第5S期 所属人体系统：运动 | 骨肿瘤

2020年发布于 Gynecol Obstet Fertil Senol 48卷第3期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 European Radiology 30卷第10期 所属人体系统：生殖 | 前列腺肿瘤

2020年发布于 Neuro-Oncology 22卷第6期 所属人体系统：其他 | 头颈部肿瘤

2020年发布于 Rofo 192卷第7期 所属人体系统：消化 | 胰腺肿瘤

2020年发布于 Journal of Gastrointestinal Oncology 11卷第2期 所属人体系统：消化 | 胰腺肿瘤

2020年发布于 Pract Radiat Oncol 10卷第6期 所属人体系统：生殖 | 乳腺肿瘤

2019年发布于 European Radiology 29卷第2期 所属人体系统：生殖 | 子宫肿瘤

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Rofo 191卷第4期 所属人体系统：其他 | 诊断/检测/评估方法

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Eur J Obstet Gynecol Reprod Biol 236卷第_期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Journal of Gynecology Obstetrics and Human Reproduction 48卷第6期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Abdom Radiol (NY) 44卷第11期 所属人体系统：消化 | 直肠癌

2019年发布于 J Am Coll Radiol 11卷第11S期 所属人体系统：生殖 | 乳腺肿瘤

2019年发布于 J Am Coll Radiol 16卷第11S期 所属人体系统：泌尿 | 肾癌

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：其他 | 腹膜肿瘤